Cilia defects upon loss of WDR4 are linked to proteasomal hyperactivity and ubiquitin shortage.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 03 02 2024
accepted: 29 08 2024
revised: 07 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

The WD repeat-containing protein 4 (WDR4) has repeatedly been associated with primary microcephaly, a condition of impaired brain and skull growth. Often, faulty centrosomes cause microcephaly, yet aberrant cilia may also be involved. Here, we show using a combination of approaches in human fibroblasts, zebrafish embryos and patient-derived cells that WDR4 facilitates cilium formation. Molecularly, we associated WDR4 loss-of-function with increased protein synthesis and concomitant upregulation of proteasomal activity, while ubiquitin precursor pools are reduced. Inhibition of proteasomal activity as well as supplementation with free ubiquitin restored normal ciliogenesis. Proteasome inhibition ameliorated microcephaly phenotypes. Thus, we propose that WDR4 loss-of-function impairs head growth and neurogenesis via aberrant cilia formation, initially caused by disturbed protein and ubiquitin homeostasis.

Identifiants

pubmed: 39251572
doi: 10.1038/s41419-024-07042-5
pii: 10.1038/s41419-024-07042-5
doi:

Substances chimiques

Proteasome Endopeptidase Complex EC 3.4.25.1
Ubiquitin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

660

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : PH144/4-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : PH144/4-3
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : PH144/6-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : 467868420
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : SFB 1074
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : SFB 1074

Informations de copyright

© 2024. The Author(s).

Références

Harris SR. Measuring head circumference: update on infant microcephaly. Can Fam Physician. 2015;61:680–4.
pubmed: 26505062 pmcid: 4541430
Alcantara D, O’Driscoll M. Congenital microcephaly. Am J Med Genet C Semin Med Genet. 2014;166C:124–39.
pubmed: 24816482 doi: 10.1002/ajmg.c.31397
Bicknell LS, Walker S, Klingseisen A, Stiff T, Leitch A, Kerzendorfer C, et al. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat Genet. 2011;43:350–5.
pubmed: 21358633 doi: 10.1038/ng.776
Griffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, et al. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet. 2008;40:232–6.
pubmed: 18157127 doi: 10.1038/ng.2007.80
Harley ME, Murina O, Leitch A, Higgs MR, Bicknell LS, Yigit G, et al. TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism. Nat Genet. 2016;48:36–43.
pubmed: 26595769 doi: 10.1038/ng.3451
Murray JE, van der Burg M, IJspeert H, Carroll P, Wu Q, Ochi T, et al. Mutations in the NHEJ component XRCC4 cause primordial dwarfism. Am J Hum Genet. 2015;96:412–24.
pubmed: 25728776 pmcid: 4375537 doi: 10.1016/j.ajhg.2015.01.013
O’Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet. 2003;33:497–501.
pubmed: 12640452 doi: 10.1038/ng1129
Ogi T, Walker S, Stiff T, Hobson E, Limsirichaikul S, Carpenter G, et al. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome. PLoS Genet. 2012;8:e1002945.
pubmed: 23144622 pmcid: 3493446 doi: 10.1371/journal.pgen.1002945
Woodbine L, Neal JA, Sasi NK, Shimada M, Deem K, Coleman H, et al. PRKDC mutations in a SCID patient with profound neurological abnormalities. J Clin Invest. 2013;123:2969–80.
pubmed: 23722905 pmcid: 3999051 doi: 10.1172/JCI67349
O’Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8:1175–85.
pubmed: 11779494 doi: 10.1016/S1097-2765(01)00408-7
Stiff T, Alagoz M, Alcantara D, Outwin E, Brunner HG, Bongers EM, et al. Deficiency in origin licensing proteins impairs cilia formation: implications for the aetiology of Meier-Gorlin syndrome. PLoS Genet. 2013;9:e1003360.
pubmed: 23516378 pmcid: 3597520 doi: 10.1371/journal.pgen.1003360
Stiff T, Casar Tena T, O'Driscoll M, Jeggo PA, Philipp M. ATR promotes cilia signalling: links to developmental impacts. Hum Mol Genet. 2016;25:1574–87.
pubmed: 26908596 pmcid: 4805311 doi: 10.1093/hmg/ddw034
Phan TP, Holland AJ. Time is of the essence: the molecular mechanisms of primary microcephaly. Genes Dev. 2021;35:1551–78.
pubmed: 34862179 pmcid: 8653793 doi: 10.1101/gad.348866.121
Casar Tena T, Burkhalter MD, Philipp M. Left-right asymmetry in the light of TOR: an update on what we know so far. Biol Cell. 2015;107:306–18.
pubmed: 25943139 pmcid: 4744706 doi: 10.1111/boc.201400094
Lovera M, Luders J. The ciliary impact of nonciliary gene mutations. Trends Cell Biol. 2021;31:876–87.
pubmed: 34183231 doi: 10.1016/j.tcb.2021.06.001
Michaud J, Kudoh J, Berry A, Bonne-Tamir B, Lalioti MD, Rossier C, et al. Isolation and characterization of a human chromosome 21q22.3 gene (WDR4) and its mouse homologue that code for a WD-repeat protein. Genomics. 2000;68:71–9.
pubmed: 10950928 doi: 10.1006/geno.2000.6258
Jin X, Guan Z, Hu N, He C, Yin P, Gong Z, et al. Structural insight into how WDR4 promotes the tRNA N7-methylguanosine methyltransferase activity of METTL1. Cell Discov. 2023;9:65.
pubmed: 37369656 pmcid: 10300002 doi: 10.1038/s41421-023-00562-y
Li J, Wang L, Hahn Q, Nowak RP, Viennet T, Orellana EA, et al. Structural basis of regulated m(7)G tRNA modification by METTL1-WDR4. Nature. 2023;613:391–7.
pubmed: 36599985 pmcid: 11179147 doi: 10.1038/s41586-022-05566-4
Ruiz-Arroyo VM, Raj R, Babu K, Onolbaatar O, Roberts PH, Nam Y. Structures and mechanisms of tRNA methylation by METTL1-WDR4. Nature. 2023;613:383–90.
pubmed: 36599982 pmcid: 9930641 doi: 10.1038/s41586-022-05565-5
Lin S, Liu Q, Lelyveld VS, Choe J, Szostak JW, Gregory RI. Mettl1/Wdr4-mediated m(7)G tRNA methylome is required for normal mRNA translation and embryonic stem cell self-renewal and differentiation. Mol Cell. 2018;71:244–55.e5.
pubmed: 29983320 pmcid: 6086580 doi: 10.1016/j.molcel.2018.06.001
Cheng IC, Chen BC, Shuai HH, Chien FC, Chen P, Hsieh TS. Wuho is a new member in maintaining genome stability through its interaction with flap endonuclease 1. PLoS Biol. 2016;14:e1002349.
pubmed: 26751069 pmcid: 4709127 doi: 10.1371/journal.pbio.1002349
Cheng W, Gao A, Lin H, Zhang W. Novel roles of METTL1/WDR4 in tumor via m(7)G methylation. Mol Ther Oncolytics. 2022;26:27–34.
pubmed: 35784404 pmcid: 9217986 doi: 10.1016/j.omto.2022.05.009
Deng L, Hua RX, Deng C, Zhu J, Zhang Z, Cheng J, et al. WDR4 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study. J Cancer. 2023;14:1293–300.
pubmed: 37283791 pmcid: 10240673 doi: 10.7150/jca.83747
Wang Z, Yu P, Zou Y, Ma J, Han H, Wei W, et al. METTL1/WDR4-mediated tRNA m(7)G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene. 2023;42:1900–12.
pubmed: 37185458 doi: 10.1038/s41388-023-02695-6
Chen B, Jiang W, Huang Y, Zhang J, Yu P, Wu L, et al. N(7)-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/beta-catenin pathway in nasopharyngeal carcinoma. Oncogene. 2022;41:2239–53.
pubmed: 35217794 doi: 10.1038/s41388-022-02250-9
Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R, et al. N(7)-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nat Commun. 2022;13:1478.
pubmed: 35304469 pmcid: 8933395 doi: 10.1038/s41467-022-29125-7
Wang YT, Chen J, Chang CW, Jen J, Huang TY, Chen CM, et al. Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment. J Clin Invest. 2017;127:2982–97.
pubmed: 28691927 pmcid: 5531412 doi: 10.1172/JCI89957
Braun DA, Shril S, Sinha A, Schneider R, Tan W, Ashraf S, et al. Mutations in WDR4 as a new cause of Galloway-Mowat syndrome. Am J Med Genet A. 2018;176:2460–5.
pubmed: 30079490 pmcid: 6289609 doi: 10.1002/ajmg.a.40489
Chen X, Gao Y, Yang L, Wu B, Dong X, Liu B, et al. Speech and language delay in a patient with WDR4 mutations. Eur J Med Genet. 2018;61:468–72.
pubmed: 29597095 doi: 10.1016/j.ejmg.2018.03.007
Shaheen R, Abdel-Salam GM, Guy MP, Alomar R, Abdel-Hamid MS, Afifi HH, et al. Mutation in WDR4 impairs tRNA m(7)G46 methylation and causes a distinct form of microcephalic primordial dwarfism. Genome Biol. 2015;16:210.
pubmed: 26416026 pmcid: 4587777 doi: 10.1186/s13059-015-0779-x
Trimouille A, Lasseaux E, Barat P, Deiller C, Drunat S, Rooryck C, et al. Further delineation of the phenotype caused by biallelic variants in the WDR4 gene. Clin Genet. 2018;93:374–7.
pubmed: 28617965 doi: 10.1111/cge.13074
Wu PR, Chiang SY, Midence R, Kao WC, Lai CL, Cheng IC, et al. Wdr4 promotes cerebellar development and locomotion through Arhgap17-mediated Rac1 activation. Cell Death Dis. 2023;14:52.
pubmed: 36681682 pmcid: 9867761 doi: 10.1038/s41419-022-05442-z
Colantonio JR, Vermot J, Wu D, Langenbacher AD, Fraser S, Chen JN, et al. The dynein regulatory complex is required for ciliary motility and otolith biogenesis in the inner ear. Nature. 2009;457:205–9.
pubmed: 19043402 doi: 10.1038/nature07520
Huang N, Zhang D, Li F, Chai P, Wang S, Teng J, et al. M-Phase Phosphoprotein 9 regulates ciliogenesis by modulating CP110-CEP97 complex localization at the mother centriole. Nat Commun. 2018;9:4511.
pubmed: 30375385 pmcid: 6207757 doi: 10.1038/s41467-018-06990-9
Spektor A, Tsang WY, Khoo D, Dynlacht BD. Cep97 and CP110 suppress a cilia assembly program. Cell. 2007;130:678–90.
pubmed: 17719545 doi: 10.1016/j.cell.2007.06.027
Hoing S, Yeh TY, Baumann M, Martinez NE, Habenberger P, Kremer L, et al. Dynarrestin, a novel inhibitor of cytoplasmic dynein. Cell Chem Biol. 2018;25:357–69 e6.
pubmed: 29396292 pmcid: 8543760 doi: 10.1016/j.chembiol.2017.12.014
Macarelli V, Leventea E, Merkle FT. Regulation of the length of neuronal primary cilia and its potential effects on signalling. Trends Cell Biol. 2023;33:979–90.
pubmed: 37302961 doi: 10.1016/j.tcb.2023.05.005
Huangfu D, Liu A, Rakeman AS, Murcia NS, Niswander L, Anderson KV. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature. 2003;426:83–7.
pubmed: 14603322 doi: 10.1038/nature02061
Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, et al. PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Curr Biol. 2005;15:1861–6.
pubmed: 16243034 doi: 10.1016/j.cub.2005.09.012
Alexandrov A, Martzen MR, Phizicky EM. Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA. RNA. 2002;8:1253–66.
pubmed: 12403464 pmcid: 1370335 doi: 10.1017/S1355838202024019
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
pubmed: 30944313 pmcid: 6447622 doi: 10.1038/s41467-019-09234-6
Vasquez SSV, van Dam J, Wheway G. An updated SYSCILIA gold standard (SCGSv2) of known ciliary genes, revealing the vast progress that has been made in the cilia research field. Mol Biol Cell. 2021;32:br13.
pubmed: 34613793 pmcid: 8694072 doi: 10.1091/mbc.E21-05-0226
Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34:D535–9.
pubmed: 16381927 doi: 10.1093/nar/gkj109
Park CW, Ryu KY. Cellular ubiquitin pool dynamics and homeostasis. BMB Rep. 2014;47:475–82.
pubmed: 24924398 pmcid: 4206721 doi: 10.5483/BMBRep.2014.47.9.128
Morozov AV, Astakhova TM, Garbuz DG, Krasnov GS, Bobkova NV, Zatsepina OG, et al. Interplay between recombinant Hsp70 and proteasomes: proteasome activity modulation and ubiquitin-independent cleavage of Hsp70. Cell Stress Chaperones. 2017;22:687–97.
pubmed: 28447215 pmcid: 5573687 doi: 10.1007/s12192-017-0792-y
Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell. 2009;36:15–27.
pubmed: 19818706 pmcid: 2771108 doi: 10.1016/j.molcel.2009.09.023
Dantuma NP, Groothuis TA, Salomons FA, Neefjes J. A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J Cell Biol. 2006;173:19–26.
pubmed: 16606690 pmcid: 2063781 doi: 10.1083/jcb.200510071
Alexandrov A, Chernyakov I, Gu W, Hiley SL, Hughes TR, Grayhack EJ, et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol Cell. 2006;21:87–96.
pubmed: 16387656 doi: 10.1016/j.molcel.2005.10.036
Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, et al. Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J. 2014;33:2020–39.
pubmed: 25063673 pmcid: 4195770 doi: 10.15252/embj.201489282
Rodrigues DC, Mufteev M, Weatheritt RJ, Djuric U, Ha KCH, Ross PJ, et al. Shifts in ribosome engagement impact key gene sets in neurodevelopment and ubiquitination in Rett syndrome. Cell Rep. 2020;30:4179–96.e11.
pubmed: 32209477 doi: 10.1016/j.celrep.2020.02.107
Senatore E, Iannucci R, Chiuso F, Delle Donne R, Rinaldi L, Feliciello A. Pathophysiology of primary cilia: signaling and proteostasis regulation. Front Cell Dev Biol. 2022;10:833086.
pubmed: 35646931 pmcid: 9130585 doi: 10.3389/fcell.2022.833086
Kasahara K, Kawakami Y, Kiyono T, Yonemura S, Kawamura Y, Era S, et al. Ubiquitin-proteasome system controls ciliogenesis at the initial step of axoneme extension. Nat Commun. 2014;5:5081.
pubmed: 25270598 doi: 10.1038/ncomms6081
Wang S, Livingston MJ, Su Y, Dong Z. Reciprocal regulation of cilia and autophagy via the MTOR and proteasome pathways. Autophagy. 2015;11:607–16.
pubmed: 25906314 pmcid: 4502771 doi: 10.1080/15548627.2015.1023983
Yen HC, Xu Q, Chou DM, Zhao Z, Elledge SJ. Global protein stability profiling in mammalian cells. Science. 2008;322:918–23.
pubmed: 18988847 doi: 10.1126/science.1160489
Yuan S, Li J, Diener DR, Choma MA, Rosenbaum JL, Sun Z. Target-of-rapamycin complex 1 (Torc1) signaling modulates cilia size and function through protein synthesis regulation. Proc Natl Acad Sci USA. 2012;109:2021–6.
pubmed: 22308353 pmcid: 3277533 doi: 10.1073/pnas.1112834109
Yao T, Cohen RE. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature. 2002;419:403–7.
pubmed: 12353037 doi: 10.1038/nature01071
Ryu KY, Maehr R, Gilchrist CA, Long MA, Bouley DM, Mueller B, et al. The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance. EMBO J. 2007;26:2693–706.
pubmed: 17491588 pmcid: 1888680 doi: 10.1038/sj.emboj.7601722
Ryu HW, Park CW, Ryu KY. Disruption of polyubiquitin gene Ubb causes dysregulation of neural stem cell differentiation with premature gliogenesis. Sci Rep. 2014;4:7026.
pubmed: 25391618 pmcid: 4229674 doi: 10.1038/srep07026
Kaiser SE, Riley BE, Shaler TA, Trevino RS, Becker CH, Schulman H, et al. Protein standard absolute quantification (PSAQ) method for the measurement of cellular ubiquitin pools. Nat Methods. 2011;8:691–6.
pubmed: 21743460 pmcid: 3196335 doi: 10.1038/nmeth.1649
Thomas S, Boutaud L, Reilly ML, Benmerah A. Cilia in hereditary cerebral anomalies. Biol Cell. 2019;111:217–31.
pubmed: 31177551 doi: 10.1111/boc.201900012
Burkhalter MD, Fralish GB, Premont RT, Caron MG, Philipp M. Grk5l controls heart development by limiting mTOR signaling during symmetry breaking. Cell Rep. 2013;4:625–32.
pubmed: 23972986 pmcid: 3792657 doi: 10.1016/j.celrep.2013.07.036
Alupei MC, Maity P, Esser PR, Krikki I, Tuorto F, Parlato R, et al. Loss of proteostasis is a pathomechanism in cockayne syndrome. Cell Rep. 2018;23:1612–9.
pubmed: 29742419 doi: 10.1016/j.celrep.2018.04.041
Frappart PO, Walter K, Gout J, Beutel AK, Morawe M, Arnold F, et al. Pancreatic cancer-derived organoids—a disease modeling tool to predict drug response. United Eur Gastroenterol J. 2020;8:594–606.
doi: 10.1177/2050640620905183
Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367–72.
pubmed: 19029910 doi: 10.1038/nbt.1511
Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794–805.
pubmed: 21254760 doi: 10.1021/pr101065j
Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456:53–9.
pubmed: 18987734 pmcid: 2581791 doi: 10.1038/nature07517
Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.
pubmed: 23618408 pmcid: 4053844 doi: 10.1186/gb-2013-14-4-r36
Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, et al. Ensembl 2018. Nucleic Acids Res. 2018;46:D754–61.
pubmed: 29155950 doi: 10.1093/nar/gkx1098
Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 2017;27:491–9.
pubmed: 28100584 pmcid: 5340976 doi: 10.1101/gr.209601.116
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Jaffe KM, Thiberge SY, Bisher ME, Burdine RD. Imaging cilia in zebrafish. Methods Cell Biol. 2010;97:415–35.
pubmed: 20719283 doi: 10.1016/S0091-679X(10)97022-2
Sokal RR, Rohlf FJ. Biometry: principals and practice of statistics in biological research. San Francisco, California: W. H. Freeman and Co Ltd; 1981.
Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–10.
pubmed: 11752295 pmcid: 99122 doi: 10.1093/nar/30.1.207

Auteurs

Martin D Burkhalter (MD)

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.

Tom Stiff (T)

Genome Damage and Stability Centre, University of Sussex, Brighton, BN1 9RQ, UK.

Lars D Maerz (LD)

Institute for Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.

Teresa Casar Tena (T)

Institute for Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.

Heike Wiese (H)

Core Unit Mass Spectrometry and Proteomics, Medical Faculty, Ulm University, 89081, Ulm, Germany.

Julian Gerhards (J)

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.

Steffen A Sailer (SA)

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.

Linh Anna Trúc Vu (LAT)

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.

Max Duong Phu (M)

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany.

Cornelia Donow (C)

Institute for Biochemistry and Molecular Biology, Ulm University, 89081, Ulm, Germany.

Marius Alupei (M)

Department of Dermatology, Ulm University, 89081, Ulm, Germany.

Sebastian Iben (S)

Department of Dermatology, Ulm University, 89081, Ulm, Germany.

Marco Groth (M)

Core Facility Next Generation Sequencing, Leibniz Institute on Aging-Fritz Lipmann Institute, 07745, Jena, Germany.

Sebastian Wiese (S)

Core Unit Mass Spectrometry and Proteomics, Medical Faculty, Ulm University, 89081, Ulm, Germany.

Joseph A Church (JA)

Department of Pediatrics, Keck School of Medicine of University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, 90033, USA.

Penelope A Jeggo (PA)

Genome Damage and Stability Centre, University of Sussex, Brighton, BN1 9RQ, UK.

Melanie Philipp (M)

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, Section of Pharmacogenomics, Eberhard-Karls-University Tübingen, 72074, Tübingen, Germany. melanie.philipp@uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH